This white paper highlights innovative methods to assess immunogenicity, showcasing data presented by Dr. Nicolas Gaudenzio, Genoskin’s Chief Scientific Officer, at the FDA-CRCG Peptide Immunogenicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback